Thursday, July 28, 2016

UPDATE 1-AstraZeneca earnings hit by waning cholesterol drug sales

* Drugmaker banking on cancer medicines for future growth

(Adds CEO comment and details on drugs)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)